Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Transgene: 2022 Full-year Results and Business Update: https://mms.businesswire.com/media/20191209005543/en/255636/5/logo_TRANSGENE.jpg
Transgene: 2022 Full-year Results and Business Update


Regulatory News:



Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today publishes its financial

EQS-News: Abivax adjusts its 2023 Financial Communication Calendar
EQS-News: Abivax adjusts its 2023 Financial Communication Calendar
EQS-News: Abivax adjusts its 2023 Financial Communication Calendar
RUBIS: FY 2022 Results: Strong operating performance, solid balance sheet and further increase in dividend
RUBIS: FY 2022 Results: Strong operating performance, solid balance sheet and further increase in dividend
RUBIS: FY 2022 Results: Strong operating performance, solid balance sheet and further increase in dividend
Sensorion Reports Full-Year 2022 Financial Results and Business Update: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg
Sensorion Reports Full-Year 2022 Financial Results and Business Update


Regulatory News:



Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the inner ear, announces today its full-year 2022

Valbiotis veröffentlicht seine Jahresergebnisse 2022 und gibt ein Update zu seiner strategischen Roadmap: https://mms.businesswire.com/media/20200205005659/en/689755/5/valbiotis-logo.jpg
Valbiotis veröffentlicht seine Jahresergebnisse 2022 und gibt ein Update zu seiner strategischen Roadmap


Valbiotis (FR0013254851 – ALVAL, PEA / SME förderungswürdig (Paris: ALVAL), ein kommerziell orientiertes Forschungs- und Entwicklungsunternehmen, das sich der wissenschaftlichen Innovation zur

Valbiotis Publishes Its 2022 Annual Results and Provides an Update on Its Strategic Roadmap: https://mms.businesswire.com/media/20200205005659/en/689755/5/valbiotis-logo.jpg
Valbiotis Publishes Its 2022 Annual Results and Provides an Update on Its Strategic Roadmap


Regulatory News:



Valbiotis (FR0013254851 – ALVAL, PEA / SME eligible) (Paris:ALVAL), a commercially oriented Research and Development company committed to scientific innovation for preventing and

GEVELOT S.A.: Weekly report of share buyback March 15, 2023
GEVELOT S.A.: Weekly report of share buyback March 15, 2023
GEVELOT S.A.: Weekly report of share buyback March 15, 2023
Prodware: Current Operating Income sees strong upturn: 29.3 M€ (+103%)  Operating Margin: 15.6%
Prodware: Current Operating Income sees strong upturn: 29.3 M€ (+103%) Operating Margin: 15.6%
Prodware: Current Operating Income sees strong upturn: 29.3 M€ (+103%) Operating Margin: 15.6%
Eutelsat selected by StarGroup to enhance its popular DTH platform StarTV in Mexico: https://mms.businesswire.com/media/20191112005524/en/397236/5/Eutelsat_Communications_logo.jpg
Eutelsat selected by StarGroup to enhance its popular DTH platform StarTV in Mexico


Regulatory News:



StarGroup, the leading telecommunications and entertainment service provider in Mexico, has once again selected Eutelsat Communications (Euronext Paris: ETL) (Paris:ETL) for

Poxel Announces Upcoming Participation at Evercore ISI’s NASH Renaissance Event: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Announces Upcoming Participation at Evercore ISI’s NASH Renaissance Event


Regulatory News:



POXEL SA (Paris:POXEL) (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic

Transgene to Present Multiple Posters Highlighting the Potential of its Exciting Immunotherapy Pipeline at AACR 2023: https://mms.businesswire.com/media/20191209005543/en/255636/5/logo_TRANSGENE.jpg
Transgene to Present Multiple Posters Highlighting the Potential of its Exciting Immunotherapy Pipeline at AACR 2023


Regulatory News:



Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, will be presenting eight posters

Sensorion Announces Agenda For R&D Day Showcasing Gene Therapy For Inner Ear Disease: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg
Sensorion Announces Agenda For R&D Day Showcasing Gene Therapy For Inner Ear Disease


Regulatory News:



Sensorion, (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company, specialising in the development of novel therapies to restore, treat and prevent within the

Valbiotis gibt den letzten Besuch des letzten Patienten in der Phase II/III REVERSE-IT Studie zu TOTUM•63 in Partnerschaft mit Nestlé Health Science bekannt: https://mms.businesswire.com/media/20200205005659/en/689755/5/valbiotis-logo.jpg
Valbiotis gibt den letzten Besuch des letzten Patienten in der Phase II/III REVERSE-IT Studie zu TOTUM•63 in Partnerschaft mit Nestlé Health Science bekannt


Valbiotis (FR0013254851 - ALVAL, PEA / SME förderungswürdig (Paris:ALVAL), ein kommerziell orientiertes Forschungs- und Entwicklungsunternehmen, das sich der wissenschaftlichen Innovation zur

Sensorion Discloses No Exposure To Silicon Valley Bank Closure: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg
Sensorion Discloses No Exposure To Silicon Valley Bank Closure


Regulatory News:



Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the ear, has learned that Silicon Valley Bank (SVB) has

Valbiotis Announces the Last Visit of the Last Patient in the Phase II/III REVERSE-IT Study on TOTUM•63, in Partnership with Nestlé Health Science: https://mms.businesswire.com/media/20200205005659/en/689755/5/valbiotis-logo.jpg
Valbiotis Announces the Last Visit of the Last Patient in the Phase II/III REVERSE-IT Study on TOTUM•63, in Partnership with Nestlé Health Science


Regulatory News:



Valbiotis (FR0013254851 – ALVAL, PEA / SME eligible) (Paris:ALVAL), a commercially oriented Research and Development company, committed to scientific innovation for preventing

Prodware: Prodware reinforces its presence in Europe with the acquisition of Westpole Belux
Prodware: Prodware reinforces its presence in Europe with the acquisition of Westpole Belux
Prodware: Prodware reinforces its presence in Europe with the acquisition of Westpole Belux
Eutelsat Communications: PCTV scales up Video services across Latin America with multi-year agreement on EUTELSAT 117 West A satellite: https://mms.businesswire.com/media/20191112005524/en/397236/5/Eutelsat_Communications_logo.jpg
Eutelsat Communications: PCTV scales up Video services across Latin America with multi-year agreement on EUTELSAT 117 West A satellite


Regulatory News:



PCTV, a subsidiary of Mexico’s leading cable operator Megacable Comunicaciones, has once again boosted its capacity on Eutelsat Communications’ (Euronext Paris: ETL) (Paris:ETL)

EQS-News: Abivax does not hold any cash or otherwise have any deposits at SVB or at any other U.S. financial institution
EQS-News: Abivax does not hold any cash or otherwise have any deposits at SVB or at any other U.S. financial institution
EQS-News: Abivax does not hold any cash or otherwise have any deposits at SVB or at any other U.S. financial institution
Transgene Appoints John C. Bell and Pedro Romero as Key Scientific Advisors: https://mms.businesswire.com/media/20191209005543/en/255636/5/logo_TRANSGENE.jpg
Transgene Appoints John C. Bell and Pedro Romero as Key Scientific Advisors


Regulatory News:



Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces the appointment of Dr.

ESI Group: Simulierung ermöglicht integrativere und sicherere Industrie für Frauen und alle Menschen: https://mms.businesswire.com/media/20210510005423/de/877137/5/2020_11_04_MKTG_ESI_Logo_ColorTagline_rgb.jpg
ESI Group: Simulierung ermöglicht integrativere und sicherere Industrie für Frauen und alle Menschen


Die ESI Group (Paris:ESI) (ISIN Code: FR0004110310, Symbol: ESI) ist ein weltweit tätiges Partnerunternehmen in Sachen Simulierung und Software für virtuelle Prototypenerstellung für diverse

Eutelsat and Intelsat Sign Multi-Orbit Contract Enhancing Connectivity with OneWeb Services: https://mms.businesswire.com/media/20191112005524/en/397236/5/Eutelsat_Communications_logo.jpg
Eutelsat and Intelsat Sign Multi-Orbit Contract Enhancing Connectivity with OneWeb Services


Regulatory News:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230308005881/en/



Eutelsat Communications (Euronext: ETL) (Paris: ETL)

GenSight Biologics Announces Publication of LUMEVOQ® Safety Data over 5-Year Period in renowned Peer-Reviewed American Journal of Ophthalmology: https://mms.businesswire.com/media/20191208005050/en/761225/5/Logo+Centre+Hospitalier+XV-XX.jpg
GenSight Biologics Announces Publication of LUMEVOQ® Safety Data over 5-Year Period in renowned Peer-Reviewed American Journal of Ophthalmology


Regulatory News:



GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal

ESI Group: A More Inclusive and Safer Industry for Women and Everyone Thanks to Simulation: https://mms.businesswire.com/media/20210510005423/de/877137/5/2020_11_04_MKTG_ESI_Logo_ColorTagline_rgb.jpg
ESI Group: A More Inclusive and Safer Industry for Women and Everyone Thanks to Simulation


Regulatory News:



ESI Group (Paris:ESI) (ISIN Code: FR0004110310, Symbol: ESI) is a global partner in simulation and virtual prototyping software for various industries. The company is committed

European Space Agency and Dassault Systèmes Sign Letter of Intent to Support Space Startups and Entrepreneurship across Europe: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
European Space Agency and Dassault Systèmes Sign Letter of Intent to Support Space Startups and Entrepreneurship across Europe


Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) (Paris:DSY) and the European Space Agency today announced the signature of a letter of intent to support the European community for

Verimatrix erhält Top-Auszeichnungen für Sicherheit mit künstlicher Intelligenz und Markenwachstum bei den Cybersecurity Excellence Awards 2023 : https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix erhält Top-Auszeichnungen für Sicherheit mit künstlicher Intelligenz und Markenwachstum bei den Cybersecurity Excellence Awards 2023


Verimatrix, (Paris:VMX) (Euronext Paris: VMX), der führende Anbieter von menschengerechten Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass das Unternehmen bei den